SATB2 is a transcriptional regulator that plays an important role in osteoblastic differentiation; it is positive in most benign and malignant tumors with osteoblastic differentiation, such as osteosarcomas, osteoblastomas, osteoid osteomas, and fibrous dysplasias [2]. Here, SATB2 is linked to cancer.